<div dir="ltr">Christian cc as above <div><br></div><div>Good morning; echo Kathy here; thanks for this and all your excellent support; </div><div><br></div><div>best</div><div><br></div><div>Nigel </div></div><br><div class="gmail_quote"><div dir="ltr" class="gmail_attr">On Wed, 24 May 2023 at 02:10, Kathy Kleiman <<a href="mailto:Kathy@kathykleiman.com">Kathy@kathykleiman.com</a>> wrote:<br></div><blockquote class="gmail_quote" style="margin:0px 0px 0px 0.8ex;border-left:1px solid rgb(204,204,204);padding-left:1ex">
<div>
<p>Hi Christian, <br>
</p>
<p>It's a huge help!<br>
</p>
<p>Many thanks, Kathy<br>
</p>
<div>On 5/23/2023 7:49 PM, Christian Wheeler
wrote:<br>
</div>
<blockquote type="cite">
<div>
<p class="MsoNormal"><span style="font-size:10pt;font-family:Arial,sans-serif">Hi
Kathy,<u></u><u></u></span></p>
<p class="MsoNormal"><span style="font-size:10pt;font-family:Arial,sans-serif"><u></u> <u></u></span></p>
<p style="margin:0in 0in 0.0001pt"><span style="font-size:10pt;font-family:Arial,sans-serif">Per
your request, I’ve gone through the
<a href="https://docs.google.com/document/d/1smLEk84K113gSGEdM4b_o1VR0vMmJk4yIkmkxX4M6Zc/edit" target="_blank">
Remaining Red Lines</a> table and added which
section/block each Red Line came from in the
<a href="https://docs.google.com/document/d/1wtLVcyWhyrCaYl1iqlAncaIyrqpS--0aPCTjpwMue7I/edit?pli=1" target="_blank">
v2 document</a>. If you look just beneath the title of
each topic (e.g. “<b><span style="background:yellow">Scoring</span></b>”)
you will find the relevant information (“<i><span style="color:black">From
</span></i><a href="https://docs.google.com/document/d/1wtLVcyWhyrCaYl1iqlAncaIyrqpS--0aPCTjpwMue7I/edit?pli=1" target="_blank"><i><span style="color:rgb(17,85,204)">v2
Discussion Draft</span></i></a><i><span style="color:black">: Section IV (Evaluation) #6”</span></i>).
I hope this helps.</span><span style="font-size:11pt"><u></u><u></u></span></p>
<p class="MsoNormal"><span style="font-size:10pt;font-family:Arial,sans-serif"><u></u> <u></u></span></p>
<div>
<div>
<div>
<p class="MsoNormal" style="background:white"><span style="font-size:10pt;font-family:Arial,sans-serif;color:rgb(8,7,7)">Kind
regards,</span><span style="font-size:10pt;font-family:Arial,sans-serif;color:black"><u></u><u></u></span></p>
<p class="MsoNormal" style="background:white"><span style="font-size:10pt;font-family:Arial,sans-serif;color:rgb(8,7,7)">Christian</span><span style="font-size:10pt;font-family:Arial,sans-serif;color:black"><u></u><u></u></span></p>
</div>
</div>
</div>
<p class="MsoNormal"><span style="font-size:11pt"><u></u> <u></u></span></p>
<p class="MsoNormal"><span style="font-size:11pt"><u></u> <u></u></span></p>
<div style="border-right:none;border-bottom:none;border-left:none;border-top:1pt solid rgb(181,196,223);padding:3pt 0in 0in">
<p class="MsoNormal"><b><span style="color:black">From: </span></b><span style="color:black">gnso-gac-closed-generics
<a href="mailto:gnso-gac-closed-generics-bounces@icann.org" target="_blank"><gnso-gac-closed-generics-bounces@icann.org></a> on
behalf of Kathy Kleiman <a href="mailto:Kathy@KathyKleiman.com" target="_blank"><Kathy@KathyKleiman.com></a><br>
<b>Date: </b>Tuesday, May 23, 2023 at 3:37 PM<br>
<b>To: </b><a href="mailto:gnso-gac-closed-generics@icann.org" target="_blank">"gnso-gac-closed-generics@icann.org"</a>
<a href="mailto:gnso-gac-closed-generics@icann.org" target="_blank"><gnso-gac-closed-generics@icann.org></a>, Melissa Peters
Allgood <a href="mailto:melissa.allgood@icann.org" target="_blank"><melissa.allgood@icann.org></a><br>
<b>Subject: </b>Re: [gnso-gac-closed-generics] Closed
Generics Asynchronous Work<u></u><u></u></span></p>
</div>
<div>
<p class="MsoNormal"><span style="font-size:11pt"><u></u> <u></u></span></p>
</div>
<p>Hi Melissa, <u></u><u></u></p>
<p>Is there any way that you/Christian could go through #1,
Remaining Red Lines Table, in the left column and identify
which "Block" of our Framework the section came from, e.g.,
<u></u><u></u></p>
<p>- Application, Evaluation or Post-delegation?<u></u><u></u></p>
<p>Out of context, things are looking a little duplicative and
it may be because they are coming from different sections of
our Framework. If you remember, it was my job, with Greg
<i>specifically to move some items from Evaluation to
Application</i> (keeping them in Evaluation, but also giving
the Applicant an opportunity to provide input directly on an
issue to be evaluated by the Panel).
<u></u><u></u></p>
<p>If we can see these section headings a little more clearly,
it will provide some usual context for the sections we are
discussing.<u></u><u></u></p>
<p>Best and tx, Kathy<u></u><u></u></p>
<div>
<p class="MsoNormal">On 5/22/2023 6:48 PM, Melissa Peters
Allgood wrote:<u></u><u></u></p>
</div>
<blockquote style="margin-top:5pt;margin-bottom:5pt">
<p class="MsoNormal">Hello again, <u></u><u></u></p>
<p class="MsoNormal"> <u></u><u></u></p>
<p class="MsoNormal">Many thanks again for the strong spirit
of compromise shared by all during today’s call.
<u></u><u></u></p>
<p class="MsoNormal"> <u></u><u></u></p>
<p class="MsoNormal">This is the email chain that encapsulates
remaining work, specifically:
<u></u><u></u></p>
<ol style="margin-top:0in" type="1" start="1">
<li style="margin-left:0in"><a href="https://urldefense.com/v3/__https:/docs.google.com/document/d/1smLEk84K113gSGEdM4b_o1VR0vMmJk4yIkmkxX4M6Zc/edit__;!!PtGJab4!83OPcACa9MYyzeaFCIsE3nfprdMk9E7AnuE0YDcnqoykfPNVehO6PyS9ayT3iMHHigwyjBxDtndJrAnVw9jAOeYWCPrAc5k$" target="_blank">Remaining Red lines table
[docs.google.com]</a> <u></u><u></u></li>
<li style="margin-left:0in">Add
notable concerns to
<a href="https://urldefense.com/v3/__https:/docs.google.com/document/d/1u0Nb9_CJ-6R_ZF4bt9wbkzxLhMKu64aKY_vzS3QixgQ/edit__;!!PtGJab4!83OPcACa9MYyzeaFCIsE3nfprdMk9E7AnuE0YDcnqoykfPNVehO6PyS9ayT3iMHHigwyjBxDtndJrAnVw9jAOeYWAgn-Cok$" target="_blank">
v3 [docs.google.com]</a>. <u></u><u></u></li>
</ol>
<p class="MsoNormal"> <u></u><u></u></p>
<p class="MsoNormal">Please don’t hesitate to reach out if you
have any questions.
<u></u><u></u></p>
<p class="MsoNormal"> <u></u><u></u></p>
<p class="MsoNormal">Melissa<u></u><u></u></p>
<p class="MsoNormal"> <u></u><u></u></p>
<p class="MsoNormal"> <u></u><u></u></p>
<div style="border-right:none;border-bottom:none;border-left:none;border-top:1pt solid rgb(181,196,223);padding:3pt 0in 0in">
<p class="MsoNormal"><b><span style="color:black">From: </span></b><span style="color:black">gnso-gac-closed-generics
<a href="mailto:gnso-gac-closed-generics-bounces@icann.org" target="_blank"><gnso-gac-closed-generics-bounces@icann.org></a>
on behalf of Melissa Peters Allgood
<a href="mailto:melissa.allgood@icann.org" target="_blank"><melissa.allgood@icann.org></a><br>
<b>Date: </b>Monday, May 22, 2023 at 8:08 AM<br>
<b>To: </b><a href="mailto:gnso-gac-closed-generics@icann.org" target="_blank">"gnso-gac-closed-generics@icann.org"</a>
<a href="mailto:gnso-gac-closed-generics@icann.org" target="_blank"><gnso-gac-closed-generics@icann.org></a><br>
<b>Subject: </b>Re: [gnso-gac-closed-generics] Closed
Generics Asynchronous Work</span><u></u><u></u></p>
</div>
<div>
<p class="MsoNormal"><span style="font-size:11pt"> </span><u></u><u></u></p>
</div>
<p class="MsoNormal">Hello, <u></u><u></u></p>
<p class="MsoNormal"> <u></u><u></u></p>
<p class="MsoNormal">Just a reminder to review and respond to
the work detailed below. My thanks to those who have already
done so.
<u></u><u></u></p>
<p class="MsoNormal"> <u></u><u></u></p>
<p class="MsoNormal">See you later today, <u></u><u></u></p>
<p class="MsoNormal">Melissa<u></u><u></u></p>
<p class="MsoNormal"> <u></u><u></u></p>
<div style="border-right:none;border-bottom:none;border-left:none;border-top:1pt solid rgb(181,196,223);padding:3pt 0in 0in">
<p class="MsoNormal"><b><span style="color:black">From: </span></b><span style="color:black">gnso-gac-closed-generics
<a href="mailto:gnso-gac-closed-generics-bounces@icann.org" target="_blank"><gnso-gac-closed-generics-bounces@icann.org></a>
on behalf of Melissa Peters Allgood
<a href="mailto:melissa.allgood@icann.org" target="_blank"><melissa.allgood@icann.org></a><br>
<b>Date: </b>Thursday, May 18, 2023 at 2:50 PM<br>
<b>To: </b><a href="mailto:gnso-gac-closed-generics@icann.org" target="_blank">"gnso-gac-closed-generics@icann.org"</a>
<a href="mailto:gnso-gac-closed-generics@icann.org" target="_blank"><gnso-gac-closed-generics@icann.org></a><br>
<b>Subject: </b>[gnso-gac-closed-generics] Closed
Generics Asynchronous Work</span><u></u><u></u></p>
</div>
<div>
<p class="MsoNormal"><span style="font-size:11pt"> </span><u></u><u></u></p>
</div>
<div>
<div>
<p class="MsoNormal"><span style="font-family:Arial,sans-serif">Hello
all, </span>
<u></u><u></u></p>
<p class="MsoNormal"><span style="font-family:Arial,sans-serif"> </span><u></u><u></u></p>
<p class="MsoNormal"><span style="font-family:Arial,sans-serif">While
you have come a long way toward a draft framework,
significant work remains with very little time to do
it. I encourage you to view the work remaining through
a lens of compromise.
</span><u></u><u></u></p>
<p class="MsoNormal"><span style="font-family:Arial,sans-serif"> </span><u></u><u></u></p>
<p class="MsoNormal"><b><i><span style="font-family:Arial,sans-serif"><a href="https://urldefense.com/v3/__https:/docs.google.com/document/d/1smLEk84K113gSGEdM4b_o1VR0vMmJk4yIkmkxX4M6Zc/edit__;!!PtGJab4!5OCuWteNnOZUXddYUk9Q7E0rVWeyo0c0Y2jQ1dTTnNSqPBoPDk_dYnCKqeN5DQQYg5JhqXO29H0fkvkQkToY8EouDljKSQYSpUk18Q$" target="_blank">Remaining Red Lines
[docs.google.com]</a></span></i></b><u></u><u></u></p>
<p class="MsoNormal"><span style="font-family:Arial,sans-serif">This
table reflects where each remaining red line issue
currently stands. The group has recently worked on the
vast majority of these and many issues within the
table offer proposed compromise. At this point, your
positions on each issue are well known and there is no
need to restate them. Instead, in this table I ask you
find compromise with the language proposed OR offer
possible solutions that meet your needs, as well as
the needs of your colleagues.
</span><u></u><u></u></p>
<p class="MsoNormal"><span style="font-family:Arial,sans-serif"> </span><u></u><u></u></p>
<p class="MsoNormal"><span style="font-family:Arial,sans-serif">Due
to time constraints, it is now incumbent upon each of
you to find strong support for your priority issues
within the red line table in order for the issue to be
included within the
<a href="https://urldefense.com/v3/__https:/docs.google.com/document/d/1u0Nb9_CJ-6R_ZF4bt9wbkzxLhMKu64aKY_vzS3QixgQ/edit__;!!PtGJab4!5OCuWteNnOZUXddYUk9Q7E0rVWeyo0c0Y2jQ1dTTnNSqPBoPDk_dYnCKqeN5DQQYg5JhqXO29H0fkvkQkToY8EouDljKSQY6fzo4dg$" target="_blank">
Closed Generic Framework v3 document.
[docs.google.com]</a> </span><u></u><u></u></p>
<p class="MsoNormal"><span style="font-family:Arial,sans-serif"> </span><u></u><u></u></p>
<p class="MsoNormal"><b><i><span style="font-family:Arial,sans-serif">Detailed
Solutions to your “Notable Concerns” in v3
Document</span></i></b><u></u><u></u></p>
<p class="MsoNormal" style="vertical-align:baseline"><span style="font-family:Arial,sans-serif;color:black">If you
flagged specific text as a “notable concern” during
our red line discussions (this was the final question
I asked for each bit of text under discussion) then
please share proposed solutions to your concern(s)<span> </span><u>via
comments</u><span> </span>in
the<span> </span><a href="https://urldefense.com/v3/__https:/docs.google.com/document/d/1u0Nb9_CJ-6R_ZF4bt9wbkzxLhMKu64aKY_vzS3QixgQ/edit__;!!PtGJab4!5OCuWteNnOZUXddYUk9Q7E0rVWeyo0c0Y2jQ1dTTnNSqPBoPDk_dYnCKqeN5DQQYg5JhqXO29H0fkvkQkToY8EouDljKSQY6fzo4dg$" title="https://docs.google.com/document/d/1u0Nb9_CJ-6R_ZF4bt9wbkzxLhMKu64aKY_vzS3QixgQ/edit" target="_blank">v3 document [docs.google.com]</a><span> </span>as soon as
possible.
</span><u></u><u></u></p>
<p class="MsoNormal" style="vertical-align:baseline"><span style="font-family:Arial,sans-serif;color:black"> </span><u></u><u></u></p>
<p class="MsoNormal" style="vertical-align:baseline"><b><i><span style="font-family:Arial,sans-serif;color:black">Minority
Statements </span></i></b><u></u><u></u></p>
</div>
</div>
<p class="MsoNormal" style="vertical-align:baseline"><span style="font-family:Arial,sans-serif;color:black">We
haven’t seen strong support for this option.</span><u></u><u></u></p>
<p class="MsoNormal" style="vertical-align:baseline"><span style="font-family:Arial,sans-serif;color:black"> </span><u></u><u></u></p>
<p class="MsoNormal" style="vertical-align:baseline"><b><i><span style="font-family:Arial,sans-serif;color:black">Remaining
Calls</span></i></b><u></u><u></u></p>
<ol style="margin-top:0in" type="1" start="1">
<li style="color:black;margin-left:0in;vertical-align:baseline">
<span style="font-family:Arial,sans-serif">22
May 2023 at 20:00 UTC</span> <u></u>
<u></u></li>
<li style="color:black;margin-left:0in;vertical-align:baseline">
<span style="font-family:Arial,sans-serif">24
May 2023 at 20:00 UTC</span> <u></u>
<u></u></li>
</ol>
<p class="MsoNormal" style="vertical-align:baseline"><span style="font-family:Arial,sans-serif;color:black"> </span><u></u><u></u></p>
<p class="MsoNormal" style="vertical-align:baseline"><span style="font-family:Arial,sans-serif;color:black">Thank
you for your continued hard work, especially
asynchronously. The finish line is in sight.
</span><u></u><u></u></p>
<p class="MsoNormal" style="vertical-align:baseline"><span style="font-family:Arial,sans-serif;color:black"> </span><u></u><u></u></p>
<p class="MsoNormal" style="vertical-align:baseline"><span style="font-family:Arial,sans-serif;color:black"> </span><u></u><u></u></p>
<p class="MsoNormal" style="vertical-align:baseline"><span style="font-family:Arial,sans-serif;color:black">All
the best,
</span><u></u><u></u></p>
<p class="MsoNormal" style="vertical-align:baseline"><span style="font-family:Arial,sans-serif;color:black">Melissa</span><u></u><u></u></p>
<p class="MsoNormal"><span style="font-size:11pt"><br>
<br>
<u></u><u></u></span></p>
<pre>_______________________________________________<u></u><u></u></pre>
<pre>gnso-gac-closed-generics mailing list<u></u><u></u></pre>
<pre><a href="mailto:gnso-gac-closed-generics@icann.org" target="_blank">gnso-gac-closed-generics@icann.org</a><u></u><u></u></pre>
<pre><a href="https://mm.icann.org/mailman/listinfo/gnso-gac-closed-generics" target="_blank">https://mm.icann.org/mailman/listinfo/gnso-gac-closed-generics</a><u></u><u></u></pre>
<pre><u></u> <u></u></pre>
<pre>_______________________________________________<u></u><u></u></pre>
<pre>By submitting your personal data, you consent to the processing of your personal data for purposes of subscribing to this mailing list accordance with the ICANN Privacy Policy (<a href="https://www.icann.org/privacy/policy" target="_blank">https://www.icann.org/privacy/policy</a>) and the website Terms of Service (<a href="https://www.icann.org/privacy/tos" target="_blank">https://www.icann.org/privacy/tos</a>). You can visit the Mailman link above to change your membership status or configuration, including unsubscribing, setting digest-style delivery or disabling delivery altogether (e.g., for a vacation), and so on.<u></u><u></u></pre>
</blockquote>
</div>
</blockquote>
</div>
_______________________________________________<br>
gnso-gac-closed-generics mailing list<br>
<a href="mailto:gnso-gac-closed-generics@icann.org" target="_blank">gnso-gac-closed-generics@icann.org</a><br>
<a href="https://mm.icann.org/mailman/listinfo/gnso-gac-closed-generics" rel="noreferrer" target="_blank">https://mm.icann.org/mailman/listinfo/gnso-gac-closed-generics</a><br>
<br>
_______________________________________________<br>
By submitting your personal data, you consent to the processing of your personal data for purposes of subscribing to this mailing list accordance with the ICANN Privacy Policy (<a href="https://www.icann.org/privacy/policy" rel="noreferrer" target="_blank">https://www.icann.org/privacy/policy</a>) and the website Terms of Service (<a href="https://www.icann.org/privacy/tos" rel="noreferrer" target="_blank">https://www.icann.org/privacy/tos</a>). You can visit the Mailman link above to change your membership status or configuration, including unsubscribing, setting digest-style delivery or disabling delivery altogether (e.g., for a vacation), and so on.</blockquote></div>